What happens when you stop
Most people regain a substantial share of the weight. Here is what the research actually found, and what that means for how you plan and budget.
Updated 2026-09-18
How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.
This is the question nobody selling these medications wants to lead with, and the one you should ask before you start: what happens if I stop?
The honest answer is that most people regain a substantial share of what they lost. A 2026 analysis published in PMC modelled the trajectory and identified a regain curve in which roughly 60% of the weight lost during treatment is regained within a year of stopping. Harvard Health, AARP and several academic medical centres have published similar guidance through 2026.
Why it happens
These drugs work by changing appetite signalling — that is the whole mechanism. Stop the drug and the signalling returns to roughly where it was, including what many people describe as "food noise" coming back. It is not a failure of willpower; it is the medication no longer doing the thing it was doing.
What that means in practice
- Treat it as ongoing, not a course. Clinicians increasingly describe GLP-1 treatment the way they describe blood-pressure medication: something you may stay on, rather than a twelve-week fix.
- Budget accordingly. If this is a multi-year commitment, the difference between a $99 and a $399 programme compounds enormously. Our twelve-month cost guide sets out the arithmetic.
- Build the habits while the medication is helping. Every source we read makes the same point: the people who hold onto more of the loss are the ones who used the appetite reduction to change what they eat and how much they move, rather than waiting.
- Protein and resistance training matter more than most people are told. That is doubly true over 50 — see GLP-1s after 50.
- Ask about a maintenance dose. Stepping down rather than stopping outright is a conversation worth having with your prescriber.
Worth knowing. Why this belongs on a price comparison site. Because if treatment is likely to be long-term, the monthly number matters far more than it appears to at sign-up. A $300 difference a month is $3,600 a year and $18,000 over five. That is the real cost of not comparing properly.
If you need to stop
- Talk to your prescriber first rather than simply not reordering — particularly if you take other medications that were adjusted around the GLP-1.
- Do not restart at your old dose after a long gap. Tolerance fades, and restarting high is how people get very unwell.
- Expect appetite to return before the weight does, which many people find the hardest part.
- A planned taper with support is a different experience from running out of medication because a supplier failed.
This is general information drawn from published research and clinical guidance, not medical advice. Decisions about stopping, tapering or maintenance belong with the clinician who prescribed it.
Read next
- GLP-1s after 50
These drugs work at any age. The risks are not identical at every age, and the muscle and bone question deserves more attention than it usually gets.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Medicare, GLP-1s and the $50 month
CMS is running a time-limited programme giving eligible Part D members certain GLP-1s for $50 a month. If you are on Medicare, read this before paying cash for anything.
- The dose ladder
Why you start low, how fast you climb, and why the price of each rung matters more than people expect.
- Tirzepatide or semaglutide?
One produced larger average weight loss in a head-to-head trial. The other is gentler on the wallet and, for some people, on the stomach.